{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:52:37Z","timestamp":1787500357567,"version":"build-2736575974"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T00:00:00Z","timestamp":1766707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":33,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-34009-z","type":"journal-article","created":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T18:13:17Z","timestamp":1766772797000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Evaluation of the effect of resveratrol on bone healing after tooth extraction in rats treated with zoledronic acid"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8289-8066","authenticated-orcid":false,"given":"Ayse","family":"Ozcan Kucuk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5013-6588","authenticated-orcid":false,"given":"Burak","family":"Ak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1759-3052","authenticated-orcid":false,"given":"Sakir Necat","family":"Yilmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7114-6021","authenticated-orcid":false,"given":"Deniz","family":"Kibar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3741-582X","authenticated-orcid":false,"given":"Ayse Betul","family":"Guk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,26]]},"reference":[{"key":"34009_CR1","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.bone.2010.11.020","volume":"48","author":"R Baron","year":"2011","unstructured":"Baron, R., Ferrari, S. & Russell, R. G. Denosumab and bisphosphonates: different mechanisms of action and effects. Bone 48, 677\u2013692. https:\/\/doi.org\/10.1016\/j.bone.2010.11.020 (2011).","journal-title":"Bone"},{"key":"34009_CR2","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s00198-007-0540-8","volume":"19","author":"RG Russell","year":"2008","unstructured":"Russell, R. G., Watts, N. B., Ebetino, F. H. & Rogers, M. J. Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy. Osteoporos. Int. 19, 733\u2013759. https:\/\/doi.org\/10.1007\/s00198-007-0540-8 (2008).","journal-title":"Osteoporos. Int."},{"key":"34009_CR3","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1210\/edrv.19.1.0327","volume":"19","author":"H Fleisch","year":"1998","unstructured":"Fleisch, H. & Bisphosphonates Mechanisms of action. Endocr. Rev. 19, 80\u2013100. https:\/\/doi.org\/10.1210\/edrv.19.1.0327 (1998).","journal-title":"Endocr. Rev."},{"key":"34009_CR4","doi-asserted-by":"publisher","first-page":"5998","DOI":"10.3390\/ijerph17165998","volume":"17","author":"G Campisi","year":"2020","unstructured":"Campisi, G. et al. Medication-related osteonecrosis of jaws (MRONJ) prevention and diagnosis: Italian consensus update 2020. Int. J. Environ. Res. Public. Health. 17, 5998. https:\/\/doi.org\/10.3390\/ijerph17165998 (2020).","journal-title":"Int. J. Environ. Res. Public. Health"},{"key":"34009_CR5","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s00784-009-0281-3","volume":"14","author":"S Hoefert","year":"2010","unstructured":"Hoefert, S., Schmitz, I., Tannapfel, A. & Eufinger, H. Importance of microcracks in etiology of bisphosphonate-related osteonecrosis of the jaw: A possible pathogenetic model of symptomatic and non-symptomatic osteonecrosis of the jaw based on scanning electron microscopy findings. Clin. Oral Investig.. 14, 271\u2013284. https:\/\/doi.org\/10.1007\/s00784-009-0281-3 (2010).","journal-title":"Clin. Oral Investig"},{"key":"34009_CR6","doi-asserted-by":"publisher","first-page":"680","DOI":"10.3390\/antiox10050680","volume":"10","author":"SW On","year":"2021","unstructured":"On, S. W., Cho, S. W., Byun, S. H. & Yang, B. E. Various therapeutic methods for the treatment of medication-related osteonecrosis of the jaw (MRONJ) and their limitations: A narrative review on new molecular and cellular therapeutic approaches. Antioxidants 10, 680. https:\/\/doi.org\/10.3390\/antiox10050680 (2021).","journal-title":"Antioxidants"},{"key":"34009_CR7","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.joms.2008.10.010","volume":"67","author":"MR Allen","year":"2009","unstructured":"Allen, M. R. & Burr, D. B. The pathogenesis of bisphosphonate-related osteonecrosis of the jaw: so many hypotheses, so few data. J. Oral Maxillofac. Surg. 67, 61\u201370. https:\/\/doi.org\/10.1016\/j.joms.2008.10.010 (2009).","journal-title":"J. Oral Maxillofac. Surg."},{"key":"34009_CR8","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1007\/s11914-018-0473-5","volume":"16","author":"J Chang","year":"2018","unstructured":"Chang, J., Hakam, A. E. & McCauley, L. K. Current Understanding of the pathophysiology of osteonecrosis of the jaw. Curr. Osteoporos. Rep. 16, 584\u2013595. https:\/\/doi.org\/10.1007\/s11914-018-0473-5 (2018).","journal-title":"Curr. Osteoporos. Rep."},{"key":"34009_CR9","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1016\/j.joms.2011.02.116","volume":"69","author":"P Lopez-Jornet","year":"2011","unstructured":"Lopez-Jornet, P. et al. Perioperative antibiotic regimen in rats treated with pamidronate plus dexamethasone and subjected to dental extraction: A study of the changes in the jaws. J. Oral Maxillofac. Surg. 69, 2488\u20132493. https:\/\/doi.org\/10.1016\/j.joms.2011.02.116 (2011).","journal-title":"J. Oral Maxillofac. Surg."},{"key":"34009_CR10","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/j.1749-6632.2010.05836.x","volume":"1218","author":"R Landesberg","year":"2011","unstructured":"Landesberg, R. et al. Potential pathophysiological mechanisms in osteonecrosis of the jaw. Ann. N. Y. Acad. Sci. 1218, 62\u201379. https:\/\/doi.org\/10.1111\/j.1749-6632.2010.05836.x (2011).","journal-title":"Ann. N Y Acad. Sci."},{"key":"34009_CR11","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/j.1601-0825.2010.01739.x","volume":"17","author":"E Allam","year":"2011","unstructured":"Allam, E., Allen, M., Chu, T. M., Ghoneima, A. & Windsor, L. J. In vivo effects of Zoledronic acid on oral mucosal epithelial cells. Oral Dis. 17, 291\u2013297 (2011).","journal-title":"Oral Dis."},{"key":"34009_CR12","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/jop.12151","volume":"43","author":"J Bagan","year":"2014","unstructured":"Bagan, J. et al. Oxidative stress in bisphosphonate-related osteonecrosis of the jaws. J. Oral Pathol. Med. 43, 371\u2013377 (2014).","journal-title":"J. Oral Pathol. Med."},{"key":"34009_CR13","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1002\/JPER.19-0385","volume":"91","author":"N Taniguchi","year":"2020","unstructured":"Taniguchi, N. et al. Bisphosphonate-induced reactive oxygen species inhibit proliferation and migration of oral fibroblasts: A pathogenesis of bisphosphonate-related osteonecrosis of the jaw. J. Periodontol.. 91, 947\u2013955 (2020).","journal-title":"J. Periodontol"},{"key":"34009_CR14","doi-asserted-by":"publisher","first-page":"26561","DOI":"10.1021\/acsomega.3c03440","volume":"8","author":"P Sungkhaphan","year":"2023","unstructured":"Sungkhaphan, P. et al. Dual-Functional drug delivery system for Bisphosphonate-Related osteonecrosis prevention and its bioinspired releasing model and in vitro assessment. ACS Omega. 8, 26561\u201326576. https:\/\/doi.org\/10.1021\/acsomega.3c03440 (2023).","journal-title":"ACS Omega"},{"key":"34009_CR15","doi-asserted-by":"publisher","first-page":"e1900226","DOI":"10.1002\/mabi.201900226","volume":"19","author":"GI Brierly","year":"2019","unstructured":"Brierly, G. I. et al. Investigation of sustained BMP delivery in the prevention of medication-related osteonecrosis of the jaw (MRONJ) in a rat model. Macromol. Biosci. 19, e1900226. https:\/\/doi.org\/10.1002\/mabi.201900226 (2019).","journal-title":"Macromol. Biosci."},{"key":"34009_CR16","doi-asserted-by":"publisher","first-page":"23371","DOI":"10.1038\/s41598-021-02637-w","volume":"11","author":"D Sharma","year":"2021","unstructured":"Sharma, D. et al. Local delivery of hydrogel-encapsulated vascular endothelial growth factor for the prevention of medication-related osteonecrosis of the jaw. Sci. Rep. 11, 23371. https:\/\/doi.org\/10.1038\/s41598-021-02637-w (2021).","journal-title":"Sci. Rep."},{"key":"34009_CR17","doi-asserted-by":"publisher","first-page":"e086","DOI":"10.1590\/1807-3107bor-2019.vol33.0086","volume":"33","author":"A Erten Taysi","year":"2019","unstructured":"Erten Taysi, A. et al. The efficacy of sustained-release Chitosan microspheres containing Recombinant human parathyroid hormone on MRONJ. Braz.  Oral.  Res. 33, e086. https:\/\/doi.org\/10.1590\/1807-3107bor-2019.vol33.0086 (2019).","journal-title":"Braz Oral Res."},{"key":"34009_CR18","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1186\/s12903-024-04792-8","volume":"24","author":"L Tao","year":"2024","unstructured":"Tao, L. et al. The preventive effect of photocrosslinked Hep\/GelMA hydrogel loaded with PRF on MRONJ. BMC Oral.  Health. 24, 1010. https:\/\/doi.org\/10.1186\/s12903-024-04792-8 (2024).","journal-title":"BMC Oral Health"},{"key":"34009_CR19","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s12011-013-9659-y","volume":"153","author":"G Ko\u00e7er","year":"2013","unstructured":"Ko\u00e7er, G. et al. Basic fibroblast growth factor attenuates bisphosphonate-induced oxidative injury but decreases zinc and copper levels in oral epithelium of rat. Biol. Trace Elem. Res. 153, 251\u2013256 (2013).","journal-title":"Biol. Trace Elem. Res."},{"issue":"4","key":"34009_CR20","doi-asserted-by":"publisher","first-page":"S601","DOI":"10.33549\/physiolres.932934","volume":"63Suppl","author":"VK Khandelwal","year":"2014","unstructured":"Khandelwal, V. K. et al. Oxidative stress plays an important role in Zoledronic acid-induced autophagy. Physiol. Res. 63Suppl (4), S601\u2013S612 (2014).","journal-title":"Physiol. Res."},{"key":"34009_CR21","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3109\/17453671003628772","volume":"81","author":"M Kuribayashi","year":"2010","unstructured":"Kuribayashi, M. et al. Vitamin E prevents steroid-induced osteonecrosis in rabbits. Acta Orthop. 81, 154\u2013160 (2010).","journal-title":"Acta Orthop."},{"key":"34009_CR22","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s00776-004-0816-1","volume":"9","author":"T Ichiseki","year":"2004","unstructured":"Ichiseki, T. et al. Oxidative stress and vascular permeability in steroid-induced osteonecrosis model. J. Orthop. Sci. 9, 509\u2013515 (2004).","journal-title":"J. Orthop. Sci."},{"key":"34009_CR23","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1093\/rheumatology\/keh518","volume":"44","author":"T Ichiseki","year":"2005","unstructured":"Ichiseki, T. et al. DNA oxidation injury in bone early after steroid administration is involved in the pathogenesis of steroid-induced osteonecrosis. Rheumatol. (Oxford). 44, 456\u2013460 (2005).","journal-title":"Rheumatol. (Oxford)"},{"key":"34009_CR24","first-page":"1440","volume":"17","author":"J Tamaoka","year":"2019","unstructured":"Tamaoka, J. et al. Osteonecrosis of the jaws caused by bisphosphonate treatment and oxidative stress in mice. Exp. Ther. Med. 17, 1440\u20131448 (2019).","journal-title":"Exp. Ther. Med."},{"key":"34009_CR25","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1007\/s00198-021-06078-z","volume":"32","author":"L Dos Santos Ferreira","year":"2021","unstructured":"Dos Santos Ferreira, L. et al. Is teriparatide therapy effective for medication-related osteonecrosis of the jaw? A systematic review and meta-analysis. Osteoporos. Int. 32, 2449\u20132459 (2021).","journal-title":"Osteoporos. Int."},{"key":"34009_CR26","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1111\/odi.14544","volume":"30","author":"M Vitale","year":"2024","unstructured":"Vitale, M. et al. Resveratrol for preventing medication-related osteonecrosis of the jaws in rats. Oral Dis. 30, 1462\u20131474. https:\/\/doi.org\/10.1111\/odi.14544 (2024).","journal-title":"Oral Dis."},{"key":"34009_CR27","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.3390\/biomedicines11051453","volume":"11","author":"H Ahmad Hairi","year":"2023","unstructured":"Ahmad Hairi, H., Jayusman, P. A. & Shuid, A. N. Revisiting Resveratrol as an osteoprotective agent: molecular evidence from in vivo and in vitro studies. Biomedicines 11, 1453 (2023).","journal-title":"Biomedicines"},{"key":"34009_CR28","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.biochi.2015.07.016","volume":"118","author":"B Kumar","year":"2015","unstructured":"Kumar, B., Iqbal, M. A., Singh, R. K. & Bamezai, R. N. Resveratrol inhibits TIGAR to promote ROS induced apoptosis and autophagy. Biochimie 118, 26\u201335. https:\/\/doi.org\/10.1016\/j.biochi.2015.07.016 (2015).","journal-title":"Biochimie"},{"key":"34009_CR29","doi-asserted-by":"crossref","unstructured":"Borsani, E. et al. Beneficial effects of concentrated growth factors and resveratrol on human osteoblasts in vitro treated with bisphosphonates. Biomed.  Res. Int. 4597321 (2018). (2018).","DOI":"10.1155\/2018\/4597321"},{"key":"34009_CR30","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1016\/j.ijom.2020.02.019","volume":"49","author":"B Movahedian Attar","year":"2020","unstructured":"Movahedian Attar, B., Razavi, S. M., Daneshmand, M. & Davoudi, A. Protective effects of Resveratrol against osteonecrosis at the extraction site in bisphosphonate-treated rats. Int. J. Oral Maxillofac. Surg. 49, 1518\u20131522 (2020).","journal-title":"Int. J. Oral Maxillofac. Surg."},{"key":"34009_CR31","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1016\/j.joms.2018.02.030","volume":"76","author":"A Ozcan-Kucuk","year":"2018","unstructured":"Ozcan-Kucuk, A., Alan, H., Gul, M. & Yolcu, U. Evaluating the effect of Resveratrol on the healing of extraction sockets in cyclosporine A-treated rats. J. Oral Maxillofac. Surg. 76, 1404\u20131413. https:\/\/doi.org\/10.1016\/j.joms.2018.02.030 (2018).","journal-title":"J. Oral Maxillofac. Surg."},{"key":"34009_CR32","doi-asserted-by":"publisher","first-page":"e177","DOI":"10.4317\/medoral.21609","volume":"22","author":"X Vidal-Guti\u00e9rrez","year":"2017","unstructured":"Vidal-Guti\u00e9rrez, X., G\u00f3mez-Clavel, J. F. & Gait\u00e1n-Cepeda, L. A. Dental extraction following zoledronate induces osteonecrosis in rat\u2019s jaw. Med. Oral Patol. Oral Cir. Bucal. 22, e177\u2013e184. https:\/\/doi.org\/10.4317\/medoral.21609 (2017).","journal-title":"Med. Oral Patol. Oral Cir. Bucal"},{"key":"34009_CR33","first-page":"716","volume":"109","author":"KS McCarty Jr","year":"1985","unstructured":"McCarty, K. S. Jr. et al. Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies. Arch. Pathol. Lab. Med. 109, 716\u2013721 (1985).","journal-title":"Arch. Pathol. Lab. Med."},{"key":"34009_CR34","doi-asserted-by":"crossref","unstructured":"Beth-Tasdogan, N. H. et al. Interventions for managing medication-related osteonecrosis of the jaw. Cochrane Database Syst. Rev. CD013993  (2022).","DOI":"10.1002\/14651858.CD012432.pub3"},{"key":"34009_CR35","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.joms.2024.03.026","volume":"82","author":"M Isleyen","year":"2024","unstructured":"Isleyen, M. et al. The preventive effect of preoperative and postoperative selenium on the medication-related osteonecrosis of the jaw: an animal study in rats. J. Oral Maxillofac. Surg. 82, 828\u2013839. https:\/\/doi.org\/10.1016\/j.joms.2024.03.026 (2024).","journal-title":"J. Oral Maxillofac. Surg."},{"key":"34009_CR36","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1158\/1078-0432.CCR-03-0105","volume":"10","author":"SH Tseng","year":"2004","unstructured":"Tseng, S. H. et al. Resveratrol suppresses the angiogenesis and tumor growth of gliomas in rats. Clin. Cancer Res. 10, 2190\u20132202 (2004).","journal-title":"Clin. Cancer Res."},{"key":"34009_CR37","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.jcms.2015.12.010","volume":"44","author":"M Zandi","year":"2016","unstructured":"Zandi, M. et al. Introducing a protocol to create bisphosphonate-related osteonecrosis of the jaw in rat animal model. J. Craniomaxillofac. Surg. 44, 271\u2013278 (2016).","journal-title":"J. Craniomaxillofac. Surg."},{"key":"34009_CR38","doi-asserted-by":"publisher","first-page":"44e1","DOI":"10.1016\/j.joms.2008.12.004","volume":"67","author":"TB Dodson","year":"2009","unstructured":"Dodson, T. B. Intravenous bisphosphonate therapy and bisphosphonate-related osteonecrosis of the jaws. J. Oral Maxillofac. Surg. 67, 44e1\u20134452 (2009).","journal-title":"J. Oral Maxillofac. Surg."},{"key":"34009_CR39","doi-asserted-by":"publisher","first-page":"792","DOI":"10.3390\/ijms19030792","volume":"19","author":"BC Akinwumi","year":"2018","unstructured":"Akinwumi, B. C., Bordun, K. A. M. & Anderson, H. D. Biological activities of stilbenoids. Int. J. Mol. Sci. 19, 792. https:\/\/doi.org\/10.3390\/ijms19030792 (2018).","journal-title":"Int. J. Mol. Sci."},{"key":"34009_CR40","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.jff.2016.01.034","volume":"22","author":"W Chen","year":"2016","unstructured":"Chen, W. et al. Oxyresveratrol: A bioavailable dietary polyphenol. J. Funct. Foods. 22, 122\u2013131. https:\/\/doi.org\/10.1016\/j.jff.2016.01.034 (2016).","journal-title":"J. Funct. Foods"},{"key":"34009_CR41","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s11095-019-2764-4","volume":"37","author":"AA Shoyaib","year":"2019","unstructured":"Shoyaib, A. A., Archie, S. R. & Karamyan, V. T. Intraperitoneal route of drug administration: should it be used in experimental animal studies? Pharm. Res. 37, 12. https:\/\/doi.org\/10.1007\/s11095-019-2764-4 (2019).","journal-title":"Pharm. Res."},{"key":"34009_CR42","doi-asserted-by":"publisher","first-page":"6113","DOI":"10.2147\/CMAR.S206301","volume":"11","author":"LX Zhong","year":"2019","unstructured":"Zhong, L. X. et al. Efficacy and safety of intraperitoneally administered Resveratrol against rat orthotopic ovarian cancers. Cancer Manag.  Res. 11, 6113\u20136124. https:\/\/doi.org\/10.2147\/CMAR.S206301 (2019).","journal-title":"Cancer Manag Res."},{"key":"34009_CR43","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/S0022-3565(25)28988-1","volume":"178","author":"G Lukas","year":"1971","unstructured":"Lukas, G., Brindle, S. D. & Greengard, P. The route of absorption of intraperitoneally administered compounds. J. Pharmacol. Exp. Ther. 178, 562\u2013566 (1971).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"34009_CR44","doi-asserted-by":"publisher","first-page":"154264","DOI":"10.1016\/j.metabol.2020.154264","volume":"110","author":"A Panagiotakou","year":"2020","unstructured":"Panagiotakou, A. et al. Extra-skeletal effects of bisphosphonates. Metabolism 110, 154264. https:\/\/doi.org\/10.1016\/j.metabol.2020.154264 (2020).","journal-title":"Metabolism"},{"key":"34009_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-015-1950-9","volume":"15","author":"S Sousa","year":"2015","unstructured":"Sousa, S. et al. Liposome encapsulated zoledronate favours M1-like behaviour in murine macrophages cultured with soluble factors from breast cancer cells. BMC Cancer. 15, 1\u201311. https:\/\/doi.org\/10.1186\/s12885-015-1950-9 (2015).","journal-title":"BMC Cancer"},{"key":"34009_CR46","doi-asserted-by":"publisher","first-page":"92","DOI":"10.14715\/cmb\/2020.66.5.17","volume":"66","author":"Y Zhang","year":"2020","unstructured":"Zhang, Y., Deng, L., Fan, J. & Zhang, Y. Effects of Resveratrol on bone metabolism and bone turnover related indexes in ovariectomized osteoporosis rats. Cell. Mol. Biol. 66, 92\u201397. https:\/\/doi.org\/10.14715\/cmb\/2020.66.5.17 (2020).","journal-title":"Cell. Mol. Biol."},{"key":"34009_CR47","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.bone.2008.10.035","volume":"44","author":"G Zhang","year":"2009","unstructured":"Zhang, G. et al. A novel semisynthesized small molecule Icaritin reduces incidence of steroid-associated osteonecrosis with Inhibition of both thrombosis and lipid-deposition in a dose-dependent manner. Bone 44, 345\u2013356 (2009).","journal-title":"Bone"},{"key":"34009_CR48","doi-asserted-by":"publisher","first-page":"824","DOI":"10.4103\/0366-6999.178952","volume":"129","author":"L Zhai","year":"2016","unstructured":"Zhai, L., Weng, X. S., Wu, Z. H. & Guo, S. G. Effect of Resveratrol on preventing steroid-induced osteonecrosis in a rabbit model. Chin. Med. J. (Engl). 129, 824\u2013830 (2016).","journal-title":"Chin. Med. J. (Engl)"},{"key":"34009_CR49","doi-asserted-by":"publisher","first-page":"12614","DOI":"10.3390\/ijms222312614","volume":"22","author":"AL Pignet","year":"2021","unstructured":"Pignet, A. L. et al. Resveratrol-induced signal transduction in wound healing. Int. J. Mol. Sci. 22, 12614. https:\/\/doi.org\/10.3390\/ijms222312614 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"34009_CR50","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1038\/s41374-021-00621-6","volume":"101","author":"Y Liu","year":"2021","unstructured":"Liu, Y. et al. Resveratrol promotes skin wound healing by regulating the miR-212\/CASP8 axis. Lab. Investig.. 101, 1363\u20131370. https:\/\/doi.org\/10.1038\/s41374-021-00621-6 (2021).","journal-title":"Lab. Investig"},{"key":"34009_CR51","doi-asserted-by":"publisher","first-page":"3446","DOI":"10.3390\/ijms21103446","volume":"21","author":"JW Shin","year":"2020","unstructured":"Shin, J. W. et al. Resveratrol inhibits particulate matter-induced inflammatory responses in human keratinocytes. Int. J. Mol. Sci. 21, 3446. https:\/\/doi.org\/10.3390\/ijms21103446 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"34009_CR52","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/S0891-5849(02)00999-1","volume":"33","author":"S Khanna","year":"2002","unstructured":"Khanna, S. et al. Dermal wound healing properties of redox-active grape seed proanthocyanidins. Free Radic.  Biol. Med. 33, 1089\u20131096. https:\/\/doi.org\/10.1016\/S0891-5849(02)00999-1 (2002).","journal-title":"Free Radic Biol. Med."},{"key":"34009_CR53","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1002\/jcb.10189","volume":"84","author":"O Kozawa","year":"2002","unstructured":"Kozawa, O., Hatakeyama, D. & Uematsu, T. Divergent regulation by p44\/p42 MAP kinase and p38 MAP kinase of bone morphogenetic protein 4 stimulated osteocalcin synthesis in osteoblasts. J. Cell. Biochem. 84, 583\u2013589. https:\/\/doi.org\/10.1002\/jcb.10189 (2002).","journal-title":"J. Cell. Biochem."},{"key":"34009_CR54","doi-asserted-by":"publisher","first-page":"E1202","DOI":"10.1152\/ajpendo.00515.2002","volume":"284","author":"H Tokuda","year":"2003","unstructured":"Tokuda, H. et al. p38 MAP kinase regulates BMP-4-stimulated VEGF synthesis via p70 S6 kinase in osteoblasts. Am. J. Physiol. Endocrinol. Metab. 284, E1202\u2013E1209. https:\/\/doi.org\/10.1152\/ajpendo.00515.2002 (2003).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"34009_CR55","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/j.ijom.2014.03.005","volume":"43","author":"RC Casarin","year":"2014","unstructured":"Casarin, R. C. et al. Resveratrol improves bone repair by modulation of bone morphogenetic proteins and osteopontin gene expression in rats. Int. J. Oral Maxillofac. Surg. 43, 900\u2013906. https:\/\/doi.org\/10.1016\/j.ijom.2014.03.005 (2014).","journal-title":"Int. J. Oral Maxillofac. Surg."},{"key":"34009_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2017.06.185","author":"DS Pino","year":"2017","unstructured":"Pino, D. S. et al. Effect of resveratrol on critical-sized calvarial defects of diabetic rats: Histometric and gene expression analysis. J. Oral Maxillofac. Surg. 75 https:\/\/doi.org\/10.1016\/j.joms.2017.06.185 (2017). 2561.e1\u20132561.e10."},{"key":"34009_CR57","doi-asserted-by":"publisher","first-page":"16634","DOI":"10.1002\/jcb.29071","volume":"120","author":"J Li","year":"2019","unstructured":"Li, J., Xin, Z. & Cai, M. The role of Resveratrol in bone marrow-derived mesenchymal stem cells from patients with osteoporosis. J. Cell. Biochem. 120, 16634\u201316642. https:\/\/doi.org\/10.1002\/jcb.29071 (2019).","journal-title":"J. Cell. Biochem."},{"key":"34009_CR58","doi-asserted-by":"publisher","first-page":"613","DOI":"10.3892\/mmr.2015.4560","volume":"13","author":"X Huang","year":"2016","unstructured":"Huang, X. et al. Dose-dependent inhibitory effects of Zoledronic acid on osteoblast viability and function in vitro. Mol. Med. Rep. 13, 613\u2013622. https:\/\/doi.org\/10.3892\/mmr.2015.4560 (2016).","journal-title":"Mol. Med. Rep."},{"key":"34009_CR59","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1016\/j.joms.2007.08.003","volume":"65","author":"RE Marx","year":"2007","unstructured":"Marx, R. E., Cillo, J. E. Jr. & Ulloa, J. J. Oral bisphosphonate induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment. J. Oral Maxillofac. Surg. 65, 2397\u20132410. https:\/\/doi.org\/10.1016\/j.joms.2007.08.003 (2007).","journal-title":"J. Oral Maxillofac. Surg."},{"key":"34009_CR60","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","volume":"72","author":"SL Ruggiero","year":"2014","unstructured":"Ruggiero, S. L. et al. American association of oral and maxillofacial surgeons position paper on medication-related osteonecrosis of the jaw \u2013 2014 update. J. Oral Maxillofac. Surg. 72, 1938\u20131956. https:\/\/doi.org\/10.1016\/j.joms.2014.04.031 (2014).","journal-title":"J. Oral Maxillofac. Surg."},{"key":"34009_CR61","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1016\/j.joms.2008.03.013","volume":"66","author":"S Khosla","year":"2008","unstructured":"Khosla, S. Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment. J. Oral Maxillofac. Surg. 66, 1320\u20131321. https:\/\/doi.org\/10.1016\/j.joms.2008.03.013 (2008).","journal-title":"J. Oral Maxillofac. Surg."},{"key":"34009_CR62","doi-asserted-by":"crossref","unstructured":"Aga\u00e7ayak, K. S., Yuksel, H., Atilgan, S., Koparal, M., U\u00e7an, M. C., \u00d6zg\u00f6z, M. E. H.M. E. T., Acikan, I. Experimental investigation of relationship between trauma and bisphosphonate-related osteonecrosis.Niger J.  Clin.  Pract.. 17(5), 559\u2013564 (2014). doi:10.4103\/1119-3077.141417.","DOI":"10.4103\/1119-3077.141417"},{"key":"34009_CR63","doi-asserted-by":"publisher","first-page":"5871","DOI":"10.3390\/nu6125871","volume":"6","author":"AM Lee","year":"2014","unstructured":"Lee, A. M. et al. Effects of Resveratrol supplementation on bone growth in young rats and microarchitecture and remodeling in ageing rats. Nutrients 6, 5871\u20135887. https:\/\/doi.org\/10.3390\/nu6125871 (2014).","journal-title":"Nutrients"},{"key":"34009_CR64","doi-asserted-by":"publisher","unstructured":"Chubb, S. A. Measurement of C-terminal telopeptide of type I collagen (CTX) in serum. Clin. Biochem. 45, 928\u2009\u2013\u200935 . https:\/\/doi.org\/10.1016\/j.clinbiochem.2012.03.035 (2012).","DOI":"10.1016\/j.clinbiochem.2012.03.035"},{"key":"34009_CR65","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.joms.2022.02.008","volume":"80","author":"SL Ruggiero","year":"2022","unstructured":"Ruggiero, S. L. et al. American association of oral and maxillofacial surgeons\u2019 position paper on medication-related osteonecrosis of the jaws\u20142022 update. J. Oral Maxillofac. Surg. 80, 920\u2013943. https:\/\/doi.org\/10.1016\/j.joms.2022.02.008 (2022).","journal-title":"J. Oral Maxillofac. Surg."},{"key":"34009_CR66","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1007\/s00223-007-9091-4","volume":"82","author":"JP Rissanen","year":"2008","unstructured":"Rissanen, J. P., Suominen, M. I., Peng, Z. & Halleen, J. M. Secreted tartrate-resistant acid phosphatase 5b is a marker of osteoclast number in human osteoclast cultures and the rat ovariectomy model. Calcif Tissue Int. 82, 108\u2013115. https:\/\/doi.org\/10.1007\/s00223-007-9091-4 (2008).","journal-title":"Calcif Tissue Int."},{"key":"34009_CR67","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1359\/JBMR.050403","volume":"20","author":"A Nenonen","year":"2005","unstructured":"Nenonen, A. et al. Serum TRACP 5b is a useful marker for monitoring alendronate treatment: comparison with other markers of bone turnover. J. Bone Min. Res. 20, 1804\u20131812. https:\/\/doi.org\/10.1359\/JBMR.050403 (2005).","journal-title":"J. Bone Min. Res."},{"issue":"1","key":"34009_CR68","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s12967-017-1230-8","volume":"15","author":"C Gross","year":"2017","unstructured":"Gross, C. et al. Osteoclast profile of medication-related osteonecrosis of the jaw secondary to bisphosphonate therapy: a comparison with osteoradionecrosis and osteomyelitis. J. Transl.  Med. 15 (1), 128. https:\/\/doi.org\/10.1186\/s12967-017-1230-8 (2017).","journal-title":"J. Transl Med."},{"key":"34009_CR69","doi-asserted-by":"publisher","first-page":"e23500","DOI":"10.1002\/dvg.23500","volume":"60","author":"S Kuroshima","year":"2022","unstructured":"Kuroshima, S., Al-Omari, F. A., Sasaki, M. & Sawase, T. Medication-related osteonecrosis of the jaw: A literature review and update. Genesis 60, e23500. https:\/\/doi.org\/10.1002\/dvg.23500 (2022).","journal-title":"Genesis"},{"key":"34009_CR70","doi-asserted-by":"publisher","first-page":"648","DOI":"10.21873\/invivo.13870","volume":"39","author":"M Kasagawa","year":"2025","unstructured":"Kasagawa, M. et al. Analysis of risedronate analog on extraction socket healing in mice. Vivo 39, 648\u2013655. https:\/\/doi.org\/10.21873\/invivo.13870 (2025).","journal-title":"Vivo"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34009-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34009-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34009-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T10:42:54Z","timestamp":1769596974000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34009-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,26]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["34009"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-34009-z","relation":{"references":[{"id-type":"doi","id":"10.1016\/j.joms.2017.06.185","asserted-by":"subject"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,26]]},"assertion":[{"value":"24 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3864"}}